Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Gwt-tud Gmbh

Clinical trials sponsored by Gwt-tud Gmbh, explained in plain language.

Not yet finished but already full! 2
Sort by
  • New drug may cut transfusions for rare bone marrow disorder

    Disease control Ongoing

    This study tests a drug called luspatercept in 70 adults with a certain type of myelodysplastic syndrome (MDS) that causes severe anemia. The goal is to see if the drug can reduce or eliminate the need for regular red blood cell transfusions. Participants receive the drug by inje…

    Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control

    Last updated Apr 28, 2026 23:51 UTC

  • New hope for lymphoma patients: targeted drug combo shows promise in late-stage trial

    Disease control Ongoing

    This study tests whether adding a targeted drug (polatuzumab vedotin) to standard chemotherapy helps people with diffuse large B-cell lymphoma that has come back or not responded to initial treatment. About 306 adults will receive either the new combo or standard therapy. The goa…

    Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control

    Last updated Apr 28, 2026 23:50 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space